The field of cancer chemoprevention has reported its first major successes, but broad translation to the clinic is not yet a reality. Here, Lippman and colleagues review the unique challenges encountered in this field, and the promise of personalized, molecularly targeted chemoprevention strategies.
- William N. William Jr
- John V. Heymach
- Scott M. Lippman